Bank of America’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Buy |
36,473
+9,571
| +36% | +$64.3K | ﹤0.01% | 5140 |
|
|
2025
Q1 | $243K | Sell |
26,902
-8,819
| -25% | -$79.7K | ﹤0.01% | 5115 |
|
|
2024
Q4 | $618K | Buy |
35,721
+1,660
| +5% | +$28.7K | ﹤0.01% | 4568 |
|
|
2024
Q3 | $544K | Buy |
34,061
+5,131
| +18% | +$82K | ﹤0.01% | 4615 |
|
|
2024
Q2 | $412K | Buy |
28,930
+6,365
| +28% | +$90.7K | ﹤0.01% | 4689 |
|
|
2024
Q1 | $320K | Sell |
22,565
-4,865
| -18% | -$68.9K | ﹤0.01% | 4808 |
|
|
2023
Q4 | $414K | Buy |
27,430
+4,086
| +18% | +$61.7K | ﹤0.01% | 4743 |
|
|
2023
Q3 | $369K | Buy |
23,344
+1,526
| +7% | +$24.1K | ﹤0.01% | 4678 |
|
|
2023
Q2 | $330K | Sell |
21,818
-11,953
| -35% | -$181K | ﹤0.01% | 4713 |
|
|
2023
Q1 | $490K | Buy |
33,771
+28,475
| +538% | +$413K | ﹤0.01% | 4638 |
|
|
2022
Q4 | $71.6K | Buy |
5,296
+1,330
| +34% | +$18K | ﹤0.01% | 5599 |
|
|
2022
Q3 | $63K | Sell |
3,966
-9,025
| -69% | -$143K | ﹤0.01% | 5727 |
|
|
2022
Q2 | $158K | Sell |
12,991
-7,880
| -38% | -$95.8K | ﹤0.01% | 5483 |
|
|
2022
Q1 | $196K | Sell |
20,871
-1,971
| -9% | -$18.5K | ﹤0.01% | 5725 |
|
|
2021
Q4 | $391K | Buy |
+22,842
| New | +$391K | ﹤0.01% | 5283 |
|